Table 1.
Resistance pattern of MRSA isolates from various sites (wound, skin, and bed) to antibiotics.
| Antibiotics |
Wounds | Skin | Bed | ||||||
|---|---|---|---|---|---|---|---|---|---|
| No. of isolates (%) | No. of isolates (%) | No. of isolates (%) | |||||||
| R | I | S | R | I | S | R | I | S | |
| AMP10 | 33 (100) | None | None | 36 (100) | None | None | 48 (100) | None | None |
| CN10 | 18 (54.5) | 7 (21.2) | 8 (24.2) | 19 (52.8) | 5 (13.9) | 12 (33.3) | 18 (37.5) | 8 (16.7) | 22 (45.8) |
| CRO30 | 23 (69.7) | 7 (21.2) | 3 (9.1) |
26 (72.2) |
6 (16.7) |
4 (11.1) |
34 (11.1) |
6 (12.5) |
5 (10.4) |
| PEF5 | 30 (90.9) | None | 3 (9.1) | 26 (72.2) | 3 (8.3) | 7 (19.4) | 32 (66.7) | 3 (6.3) | 13 (27.1) |
| CIP5 | 17 (51.5) | 3 (9.1) | 13 (39.4) | 17 (47.2) | 3 (47.2) | 16 (44.4) | 17 (35.4) | 4 (8.3) | 27 (56.3) |
R: resistance, I: intermediate, S: sensitive, Amp10: ampicillin 10 µg, CN10: gentamicin 10 µg, CRO30: ceftriaxone 30 µg, PEF5: pefloxacin 5 µg, CIP5: ciprofloxacin 5 µg.